Breast Cancer: Medical Treatments
Commons · Question 65167 · Tabled 4 Jul 2025 · Department of Health and Social Care · Official record
Answered 10 Jul 2025
Question
Asked by Andrew Snowden
To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential impact of the severity modifier introduced by NICE in 2022 on access to new treatments for secondary breast cancer.
Answer
Answered by Karin Smyth, 10 Jul 2025
The National Institute for Health and Care Excellence (NICE) is responsible for the methods and processes that it uses in the development of its recommendations. The severity modifier was introduced in January 2022 as part of a number of changes intended ...